论文部分内容阅读
粒细胞 /巨噬细胞集落刺激因子 (ＧＭ ＣＳＦ)在恶性肿瘤化疗所致的白细胞 (ＷＢＣ)和中性粒细胞 (ＡＮＣ)下降的防治作用已显而易见 ,并在临床上得到广泛运用和肯定。但合适的给药时间对肿瘤化疗起着一定作用。我们于 1998年 10月～ 1999年 8月应用利百多 (国产基因重组人粒细
The preventive and therapeutic effects of granulocyte / macrophage colony stimulating factor (GM CSF) on the decline of leucocyte (WBC) and neutrophil (ANC) in malignant tumor chemotherapy have been obvious and have been widely used and affirmed clinically. However, the appropriate time of administration plays a role in tumor chemotherapy. We in 1998 October ~ August 1999 application of Riboside (domestic gene recombinant human grain size